Company intelligence / Profile preview

Metrion Biosciences

Cambridge, England, United Kingdommetrionbiosciences.com ↗

Ownership: Private
Employees: ~75
Development stage: Preclinical

Overview

Metrion Biosciences provides specialist contract research services focused on preclinical ion channel drug discovery. They are recognized internationally for high-quality data in cardiac safety profiling and neuroscience screening but do not develop their own clinical pipeline or drugs. Their expertise supports pharmaceutical R&D from target validation through lead optimization using advanced electrophysiological techniques.

Therapeutic areas: PulmonologyImmunologyPsychiatryCardiovascularNeurology
Modalities: Small moleculePeptidesBiologicDevice
Industry: Drug Discovery Services

Partnerships

Notable collaborations with pharmaceutical companies globally via fee-for-service or project-based partnershipsAcademic collaborations

Beyond the preview

Go deeper on Metrion Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Metrion Biosciences.

Explore the full profile